
### [MONDO:0005439](http://purl.obolibrary.org/obo/MONDO_0005439)
**Label:** familial hypercholesterolemia

**Subclasses:** [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0011374](http://purl.obolibrary.org/obo/MONDO_0011374) (autosomal recessive hypercholesterolemia), [MONDO:0007751](http://purl.obolibrary.org/obo/MONDO_0007751) (hypercholesterolemia, autosomal dominant, type b), [MONDO:0007750](http://purl.obolibrary.org/obo/MONDO_0007750) (hypercholesterolemia, familial), [MONDO:0011369](http://purl.obolibrary.org/obo/MONDO_0011369) (hypercholesterolemia, autosomal dominant, 3), [MONDO:0011207](http://purl.obolibrary.org/obo/MONDO_0011207) (xanthomatosis, susceptibility to), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0006600](http://purl.obolibrary.org/obo/GO_0006600) (creatine metabolic process), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0034190](http://purl.obolibrary.org/obo/GO_0034190) (apolipoprotein receptor binding), [GO:0004301](http://purl.obolibrary.org/obo/GO_0004301) (epoxide hydrolase activity), [GO:0007259](http://purl.obolibrary.org/obo/GO_0007259) (JAK-STAT cascade), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0034189](http://purl.obolibrary.org/obo/GO_0034189) (very-low-density lipoprotein particle binding), [GO:0048009](http://purl.obolibrary.org/obo/GO_0048009) (insulin-like growth factor receptor signaling pathway), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0045540](http://purl.obolibrary.org/obo/GO_0045540) (regulation of cholesterol biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0033885](http://purl.obolibrary.org/obo/GO_0033885) (10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0030134](http://purl.obolibrary.org/obo/GO_0030134) (COPII-coated ER to Golgi transport vesicle), [GO:0032799](http://purl.obolibrary.org/obo/GO_0032799) (low-density lipoprotein receptor particle metabolic process), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:1905601](http://purl.obolibrary.org/obo/GO_1905601) (negative regulation of receptor-mediated endocytosis involved in cholesterol transport), [GO:0042158](http://purl.obolibrary.org/obo/GO_0042158) (lipoprotein biosynthetic process), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0042953](http://purl.obolibrary.org/obo/GO_0042953) (lipoprotein transport), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001920](http://purl.obolibrary.org/obo/GO_0001920) (negative regulation of receptor recycling), [GO:1990666](http://purl.obolibrary.org/obo/GO_1990666) (PCSK9-LDLR complex), [GO:1990667](http://purl.obolibrary.org/obo/GO_1990667) (PCSK9-AnxA2 complex), [GO:0030121](http://purl.obolibrary.org/obo/GO_0030121) (AP-1 adaptor complex), [GO:0010874](http://purl.obolibrary.org/obo/GO_0010874) (regulation of cholesterol efflux), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0030122](http://purl.obolibrary.org/obo/GO_0030122) (AP-2 adaptor complex), [GO:0036464](http://purl.obolibrary.org/obo/GO_0036464) (cytoplasmic ribonucleoprotein granule), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0006953](http://purl.obolibrary.org/obo/GO_0006953) (acute-phase response), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0010886](http://purl.obolibrary.org/obo/GO_0010886) (positive regulation of cholesterol storage), [GO:0019212](http://purl.obolibrary.org/obo/GO_0019212) (phosphatase inhibitor activity), [GO:0070971](http://purl.obolibrary.org/obo/GO_0070971) (endoplasmic reticulum exit site), [GO:0010884](http://purl.obolibrary.org/obo/GO_0010884) (positive regulation of lipid storage), [GO:0019838](http://purl.obolibrary.org/obo/GO_0019838) (growth factor binding), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0042577](http://purl.obolibrary.org/obo/GO_0042577) (lipid phosphatase activity), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:0032803](http://purl.obolibrary.org/obo/GO_0032803) (regulation of low-density lipoprotein particle receptor catabolic process), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0032802](http://purl.obolibrary.org/obo/GO_0032802) (low-density lipoprotein particle receptor catabolic process), [GO:0032805](http://purl.obolibrary.org/obo/GO_0032805) (positive regulation of low-density lipoprotein particle receptor catabolic process), [GO:1905596](http://purl.obolibrary.org/obo/GO_1905596) (negative regulation of low-density lipoprotein particle receptor binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:1905598](http://purl.obolibrary.org/obo/GO_1905598) (negative regulation of low-density lipoprotein receptor activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0097176](http://purl.obolibrary.org/obo/GO_0097176) (epoxide metabolic process), [GO:0046272](http://purl.obolibrary.org/obo/GO_0046272) (stilbene catabolic process), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0004903](http://purl.obolibrary.org/obo/GO_0004903) (growth hormone receptor activity), [GO:0032355](http://purl.obolibrary.org/obo/GO_0032355) (response to estradiol), [GO:0010469](http://purl.obolibrary.org/obo/GO_0010469) (regulation of receptor activity), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0046839](http://purl.obolibrary.org/obo/GO_0046839) (phospholipid dephosphorylation), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0030169](http://purl.obolibrary.org/obo/GO_0030169) (low-density lipoprotein particle binding), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007041](http://purl.obolibrary.org/obo/GO_0007041) (lysosomal transport), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0012506](http://purl.obolibrary.org/obo/GO_0012506) (vesicle membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0016540](http://purl.obolibrary.org/obo/GO_0016540) (protein autoprocessing), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0022008](http://purl.obolibrary.org/obo/GO_0022008) (neurogenesis), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0030547](http://purl.obolibrary.org/obo/GO_0030547) (receptor inhibitor activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0002092](http://purl.obolibrary.org/obo/GO_0002092) (positive regulation of receptor internalization), [GO:0006573](http://purl.obolibrary.org/obo/GO_0006573) (valine metabolic process), [GO:0090181](http://purl.obolibrary.org/obo/GO_0090181) (regulation of cholesterol metabolic process), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0043086](http://purl.obolibrary.org/obo/GO_0043086) (negative regulation of catalytic activity), [GO:0019871](http://purl.obolibrary.org/obo/GO_0019871) (sodium channel inhibitor activity), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0031983](http://purl.obolibrary.org/obo/GO_0031983) (vesicle lumen), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:2000650](http://purl.obolibrary.org/obo/GO_2000650) (negative regulation of sodium ion transmembrane transporter activity), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0043651](http://purl.obolibrary.org/obo/GO_0043651) (linoleic acid metabolic process), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0006549](http://purl.obolibrary.org/obo/GO_0006549) (isoleucine metabolic process), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0010921](http://purl.obolibrary.org/obo/GO_0010921) (regulation of phosphatase activity), [GO:0042976](http://purl.obolibrary.org/obo/GO_0042976) (activation of Janus kinase activity), [GO:0019439](http://purl.obolibrary.org/obo/GO_0019439) (aromatic compound catabolic process), [GO:0044236](http://purl.obolibrary.org/obo/GO_0044236) (multicellular organism metabolic process), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:0000255](http://purl.obolibrary.org/obo/GO_0000255) (allantoin metabolic process), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0034383](http://purl.obolibrary.org/obo/GO_0034383) (low-density lipoprotein particle clearance), [GO:0035473](http://purl.obolibrary.org/obo/GO_0035473) (lipase binding), [GO:0015643](http://purl.obolibrary.org/obo/GO_0015643) (toxic substance binding), [GO:0060396](http://purl.obolibrary.org/obo/GO_0060396) (growth hormone receptor signaling pathway), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0005041](http://purl.obolibrary.org/obo/GO_0005041) (low-density lipoprotein receptor activity), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0046427](http://purl.obolibrary.org/obo/GO_0046427) (positive regulation of JAK-STAT cascade), [GO:0070195](http://purl.obolibrary.org/obo/GO_0070195) (growth hormone receptor complex), [GO:0004865](http://purl.obolibrary.org/obo/GO_0004865) (protein serine/threonine phosphatase inhibitor activity), [GO:0004864](http://purl.obolibrary.org/obo/GO_0004864) (protein phosphatase inhibitor activity), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0010989](http://purl.obolibrary.org/obo/GO_0010989) (negative regulation of low-density lipoprotein particle clearance), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0032870](http://purl.obolibrary.org/obo/GO_0032870) (cellular response to hormone stimulus), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0010744](http://purl.obolibrary.org/obo/GO_0010744) (positive regulation of macrophage derived foam cell differentiation), [GO:0030212](http://purl.obolibrary.org/obo/GO_0030212) (hyaluronan metabolic process), [GO:0090118](http://purl.obolibrary.org/obo/GO_0090118) (receptor-mediated endocytosis involved in cholesterol transport), [GO:0034374](http://purl.obolibrary.org/obo/GO_0034374) (low-density lipoprotein particle remodeling), [GO:0006101](http://purl.obolibrary.org/obo/GO_0006101) (citrate metabolic process), [GO:0006105](http://purl.obolibrary.org/obo/GO_0006105) (succinate metabolic process), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0006103](http://purl.obolibrary.org/obo/GO_0006103) (2-oxoglutarate metabolic process), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0002539](http://purl.obolibrary.org/obo/GO_0002539) (prostaglandin production involved in inflammatory response), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle), [GO:0009743](http://purl.obolibrary.org/obo/GO_0009743) (response to carbohydrate), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0046449](http://purl.obolibrary.org/obo/GO_0046449) (creatinine metabolic process), [GO:0006107](http://purl.obolibrary.org/obo/GO_0006107) (oxaloacetate metabolic process), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0019530](http://purl.obolibrary.org/obo/GO_0019530) (taurine metabolic process), [GO:0019898](http://purl.obolibrary.org/obo/GO_0019898) (extrinsic component of membrane), [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron), 

**Class expressions from DL-Learner:**

- Thing 55.35%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) 51.43%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.71%
- [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron) 50.71%
- [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle) 50.71%
- [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle) 50.71%
- [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle) 50.71%
- [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron) 50.71%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.71%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) 47.58%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 47.58%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 47.58%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 47.58%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 47.58%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 47.58%


